Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunological profiling of patients with ulcerative colitis leads to identification of two inflammatory conditions and CD1a as a disease marker.

Journal of translational medicine - 3 Nov 2016

Föhlinger M, Palamides P, Mansmann U, Beigel F, Siebeck M, Gropp R

Abstract excerpt

BACKGROUND: Conventional approaches to understand mechanisms underlying the development of pathological manifestations in ulcerative colitis (UC) mostly rely on identification of certain cell types and cytokines followed by verification of their roles in vitro and in vivo. In light of the highly dynamic processes in UC, requiring the cross talk of immune cells, epithelial-, endothelial-, muscle cells and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, CD1
Share to Biomarkers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Colitis, Ulcerative

Share to Demography

Share to Inflammation

Share to Leukocyte Count

Share to Lymphocytes

Source

Open in PubMed Open full text

Identifiers

PMID: 27809916
DOI: 10.1186/s12967-016-1048-9
PMCID: PMC5094062

Genes

HGF
CCR2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunological profiling of patients with ulcerative colitis leads to identification of two inflammatory conditions and CD1a as a disease marker.PMID 27809916Read ↗

Integrative biomarker discovery and immune profiling for ulcerative colitis: a multi-methodological approachSemantic proximity Read ↗

Ulcerative colitis immune cell landscapes and differentially expressed gene signatures determine novel regulators and predict clinical response to biologic therapySemantic proximity Read ↗

Decoding Cytokine Networks in Ulcerative Colitis to Identify Pathogenic Mechanisms and Therapeutic TargetsSemantic proximity Read ↗

Mass cytometry reveals systemic and local immune signatures that distinguish inflammatory bowel diseasesSemantic proximity Read ↗

A blood-based prognostic biomarker in inflammatory bowel diseaseSemantic proximity Read ↗

Evaluation of colorectal cancer in ulcerative colitis reveals key immune factors during its malignant transformationSemantic proximity Read ↗

Myeloid cell influx into the colonic epithelium is associated with disease severity and non-response to anti-Tumor Necrosis Factor Therapy in patients with Ulcerative ColitisSemantic proximity Read ↗

Assessing Cellular and Transcriptional diversity of IIeal Mucosa amongst Treatment Naïve and Treated Crohn’s diseaseSemantic proximity Read ↗

Multi-omics empowered deep phenotyping of ulcerative colitisSemantic proximity Read ↗

Pro-inflammatory innate-like T cells are expanded in the blood and inflamed intestine in Crohn’s DiseaseSemantic proximity Read ↗

Tissue-embedded CD4⁺ plasticity defines mucosal immunity in Inflammatory Bowel DiseaseSemantic proximity Read ↗

Multiomics-empowered Deep Phenotyping of Ulcerative Colitis Identifies Biomarker Signatures Reporting Functional Remission States.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.